Literature DB >> 11587924

Multidrug resistance in Gram-negative bacteria.

K Poole1.   

Abstract

Broadly specific, so-called multidrug, efflux mechanisms are now known to contribute significantly to intrinsic and acquired multidrug resistance in a number of Gram-negative bacteria, and the boom in bacterial genomics has confirmed the distribution of these systems in all bacteria. This broad distribution of multidrug transporters lends a certain credibility to suggestions that they play a housekeeping role in the cell, beyond any contributions they may make to antimicrobial efflux and resistance. In many instances, these transporters are dispensable, arguing against their carrying out essential cellular functions; nevertheless, the multiplicity of these broadly specific export systems within a given microorganism, often with overlapping substrate specificity, may explain the dispensability of individual exporters. Whatever their intended function, however, their conservation in so many organisms highlights their probable general importance in antimicrobial resistance, particularly in Gram-negative bacteria whose outer membranes work synergistically with many of these export systems to promote drug exclusion.

Mesh:

Substances:

Year:  2001        PMID: 11587924     DOI: 10.1016/s1369-5274(00)00242-3

Source DB:  PubMed          Journal:  Curr Opin Microbiol        ISSN: 1369-5274            Impact factor:   7.934


  58 in total

1.  Membrane topology of the multidrug transporter MdfA: complementary gene fusion studies reveal a nonessential C-terminal domain.

Authors:  Julia Adler; Eitan Bibi
Journal:  J Bacteriol       Date:  2002-06       Impact factor: 3.490

2.  Use of high-performance liquid chromatography to study the pharmacokinetics of colistin sulfate in rats following intravenous administration.

Authors:  Jian Li; Robert W Milne; Roger L Nation; John D Turnidge; Timothy C Smeaton; Kingsley Coulthard
Journal:  Antimicrob Agents Chemother       Date:  2003-05       Impact factor: 5.191

3.  In vivo and in vitro evidence that TtgV is the specific regulator of the TtgGHI multidrug and solvent efflux pump of Pseudomonas putida.

Authors:  Antonia Rojas; Ana Segura; María Eugenia Guazzaroni; Wilson Terán; Ana Hurtado; María Trinidad Gallegos; Juan L Ramos
Journal:  J Bacteriol       Date:  2003-08       Impact factor: 3.490

4.  The mexR repressor of the mexAB-oprM multidrug efflux operon in Pseudomonas aeruginosa: characterization of mutations compromising activity.

Authors:  Lateef Adewoye; Ainsley Sutherland; Ramakrishnan Srikumar; Keith Poole
Journal:  J Bacteriol       Date:  2002-08       Impact factor: 3.490

5.  Structure of the periplasmic component of a bacterial drug efflux pump.

Authors:  Matthew K Higgins; Evert Bokma; Eva Koronakis; Colin Hughes; Vassilis Koronakis
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-28       Impact factor: 11.205

6.  Small-molecule inhibitors specifically targeting type III secretion.

Authors:  R Nordfelth; A M Kauppi; H A Norberg; H Wolf-Watz; M Elofsson
Journal:  Infect Immun       Date:  2005-05       Impact factor: 3.441

7.  Discovery of FabH/FabF inhibitors from natural products.

Authors:  Katherine Young; Hiranthi Jayasuriya; John G Ondeyka; Kithsiri Herath; Chaowei Zhang; Srinivas Kodali; Andrew Galgoci; Ronald Painter; Vickie Brown-Driver; Robert Yamamoto; Lynn L Silver; Yingcong Zheng; Judith I Ventura; Janet Sigmund; Sookhee Ha; Angela Basilio; Francisca Vicente; José Rubén Tormo; Fernando Pelaez; Phil Youngman; Doris Cully; John F Barrett; Dennis Schmatz; Sheo B Singh; Jun Wang
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191

8.  The assembled structure of a complete tripartite bacterial multidrug efflux pump.

Authors:  Martyn F Symmons; Evert Bokma; Eva Koronakis; Colin Hughes; Vassilis Koronakis
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-02       Impact factor: 11.205

9.  Fmt bypass in Pseudomonas aeruginosa causes induction of MexXY efflux pump expression.

Authors:  Ruth E Caughlan; Shubha Sriram; Denis M Daigle; Angela L Woods; Jennifer Buco; Ron L Peterson; Joann Dzink-Fox; Susan Walker; Charles R Dean
Journal:  Antimicrob Agents Chemother       Date:  2009-09-28       Impact factor: 5.191

10.  Differential impact of MexB mutations on substrate selectivity of the MexAB-OprM multidrug efflux pump of Pseudomonas aeruginosa.

Authors:  Jocelyn K Middlemiss; Keith Poole
Journal:  J Bacteriol       Date:  2004-03       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.